Skip to content
Scintria
ToolsGrant writerFunding
HomeLiteratureClinical trialsEvidence LabProtocol packData analysisLearnProjectsLibraryReferencesApplications
Start free
ScintriaStart free

Learn / Clinical Research Management / Safety in clinical trials

Adverse events and serious adverse events

13 minute read · 6-question quiz

Download this lesson as a colour Word or PDF study guide with the figures and answers. Included in paid plans; reading and quizzes stay free.Sign in

What you will learn

  • Define adverse event, adverse reaction and serious adverse event

  • Grade severity and assess causality and expectedness

  • Record adverse events completely and consistently

Safety reporting is central to GCP. Participants must be told about risks, and the trial must detect and respond to harm quickly.

Definitions

  • Adverse event (AE): any untoward medical occurrence in a participant given a product, whether or not it is related to the product. It can be a sign, symptom, abnormal laboratory result or disease.
  • Adverse drug reaction (ADR): an AE for which a causal relationship with the product is at least a reasonable possibility.
  • Serious adverse event (SAE): any AE that
  • results in death,
  • is life-threatening,
  • requires hospitalisation or prolongs existing hospitalisation,
  • results in persistent or significant disability or incapacity,
  • is a congenital anomaly or birth defect, or
  • is another medically important event.
  • Suspected unexpected serious adverse reaction (SUSAR): a serious reaction suspected to be related to the product and not listed as an expected effect in the reference safety information, such as the investigator's brochure.

Serious is not the same as severe

Severity describes the intensity of an event (mild, moderate, severe). Seriousness is defined by outcome or the criteria above. A severe headache can be non-serious; a mild-seeming condition requiring hospital admission is serious.

SeveritySeriousnessCausalityMild, moderate, severeDescribes intensityOften graded by CTCAE orDAIDSDeath, life-threat,hospitalisationDisability, birth defectDrives reporting timelinesRelated or not relatedJudged by the investigatorConsiders time, othercauses
Three separate assessments for every adverse event.

Assessing causality

The investigator judges whether the product may have caused the event, considering:

  • Timing: did it begin after the product was given, and does it fit the expected time pattern?
  • Dechallenge and rechallenge: did it improve when the product stopped, and recur if restarted?
  • Biological plausibility and known effects of the product class.
  • Alternative explanations: disease, other drugs, infections.

Categories commonly used are not related, unlikely, possible, probable, definite. When uncertain, a more cautious assessment is preferred. The sponsor also makes its own assessment.

Recording adverse events

  • Ask open questions at every visit and review diaries, laboratory results and records.
  • Record description, onset and end dates, severity, seriousness, causality, action taken and outcome.
  • Use diagnoses rather than a list of separate symptoms where possible.
  • Record concomitant medicines taken to treat the event.
  • Follow each event until it resolves or stabilises.

Worked example: classifying events

Participants in a malaria trial report the following.

  • Mild headache for one day, resolved without treatment: AE, mild, not serious.
  • Severe vomiting needing an overnight hospital stay: AE, serious because of hospitalisation. Severity is also severe.
  • Elevated liver enzymes three times the upper limit, not listed in the IB, judged possibly related: AE; if it also meets a serious criterion, it becomes a SUSAR and needs expedited reporting.
  • Road traffic injury unrelated to the product: AE, not related. If hospitalised, still an SAE and reported as such.

All are recorded. Seriousness decides how fast the sponsor and committees must be told.

Report, even if you think it is unrelated

Investigators report all SAEs to the sponsor immediately, usually within 24 hours of becoming aware. The sponsor, with wider information, decides on relatedness across the programme.

Underreporting is a major risk

Staff may avoid recording events that seem minor or that embarrass the site. This hides safety signals and undermines the trial. Create a culture where reporting is encouraged and blame-free.

Check yourself

Take an event you have seen on a trial: classify it by severity, seriousness and causality. Do your three answers differ?

Summary

  • An AE is any untoward event, related or not; an ADR is suspected to be caused by the product.

  • SAE criteria are death, life-threatening event, hospitalisation, disability, birth defect and other medically important events.

  • Severity, seriousness and causality are separate assessments.

  • Record completely, follow to resolution and report SAEs promptly.

Check your understanding

Question 1
1

An adverse event is:

Question 2
2

Which makes an event serious?

Question 3
3

A SUSAR is:

Question 4
4

An investigator should report SAEs to the sponsor:

Question 5
5

Severe headache without hospitalisation is:

Question 6
6

Causality assessment considers:

Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.

Investigational product managementSafety reporting timelines and oversight committees